Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Systematic reviews and meta-analyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and reliably. The clarity and transparency of these reports, however, is not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users.

Since the development of the QUOROM (QUality Of Reporting Of Meta-analysis) Statement—a reporting guideline published in 1999—there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realizing these issues, an international group that included experienced authors and methodologists developed PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions.

The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this Explanation and Elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA Statement, this document, and the associated Web site (http://www.prisma-statement.org/) should be helpful resources to improve reporting of systematic reviews and meta-analyses.

/pdf/the-prisma-statement-for-reporting-systematic-reviews-and-3j53e5oe33.pdf

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

The Cochrane Handbook for Systematic Reviews of Interventions is the official document that describes in detail the process of preparing and maintaining Cochrane systematic reviews on the effects of healthcare interventions.

/pdf/cochrane-handbook-for-systematic-reviews-of-interventions-1xbdy6uvru.pdf

Cochrane Handbook for Systematic Reviews of Interventions

Systematic reviews and meta-analyses are essential to summarise evidence relating to efficacy and safety of healthcare interventions accurately and reliably. The clarity and transparency of these reports, however, are not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users. Since the development of the QUOROM (quality of reporting of meta-analysis) statement—a reporting guideline published in 1999—there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realising these issues, an international group that included experienced authors and methodologists developed PRISMA (preferred reporting items for systematic reviews and meta-analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions. The PRISMA statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this explanation and elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA statement, this document, and the associated website (www.prisma-statement.org/) should be helpful resources to improve reporting of systematic reviews and meta-analyses.

/pdf/the-prisma-statement-for-reporting-systematic-reviews-and-48ibbzju0k.pdf

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Radiogenomics and radiomics of Skull Base Chordoma: machine learning-based classification of genetic signatures and clinical outcomes by multiparametric MRI

Introduction: Esthesioneuroblastoma is an uncommon sinonasal malignancy which often involves the skull base. Recurrence in the head and neck is well described, but data on patterns and management of intracranial recurrence are sparse. The aim of this study is to characterize the patterns of intracranial recurrence of esthesioneuroblastoma. 

Patterns and Management of Intracranial Recurrence of Esthesioneuroblastoma

The authors present a case of 10-year-old female presenting with headaches and fever following a retrosigmoid craniotomy with incomplete prepontine neurenteric cyst resection. Neurological examination was unremarkable. Magnetic resonance imaging demonstrated a prepontine hyperintense lesion. Endonasal approach offers direct access to the cyst and greatest chance of total resection. Following complete resection via the endoscopic endonasal transclival approach, multilayer skull base reconstruction was performed. Patient tolerated the procedure well and her headaches resolved completely. 

Endoscopic Endonasal Transclival Resection of a Recurrent Neurenteric Cyst

Introduction: Craniopharyngiomas are benign tumors with aggressive biology. These tumors are increasingly resected via endoscopic endonasal surgery (EES). This study investigates risk factors for residual and recurrence for patients with craniopharyngiomas who underwent first time resection via EES. 

Risk Factors for Tumor Residual and Recurrence in First-Time Resection of Craniopharyngioma through Endoscopic Endonasal Approach

Background: Ventrally compressive craniocervical junction (CCJ) pathologies, ranging from basilar invagination to pannus formation, remain a poorly understood disease process. Decompression or correction of the underlying CCJ process requires accurate understanding and description, neither of which are consistently achieved in the literature. The anatomical features of a large patient series may provide a novel classification system for CCJ disorders. 

Paul Garner

Papers

Radiogenomics and radiomics of Skull Base Chordoma: machine learning-based classification of genetic signatures and clinical outcomes by multiparametric MRI

Patterns and Management of Intracranial Recurrence of Esthesioneuroblastoma

Endoscopic Endonasal Transclival Resection of a Recurrent Neurenteric Cyst

Risk Factors for Tumor Residual and Recurrence in First-Time Resection of Craniopharyngioma through Endoscopic Endonasal Approach

A Novel Classification of Compressive Craniocervical Junction Disorders